Mark James Daniel - 14 Oct 2025 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Reporting relationship: Chief Financial Officer
Issuer ticker: ATOS
Reported as of: 14 Oct 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Oct 2025, 16:10:03 UTC
Next SEC filing: 30 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mark James Daniel

Key filing fact

Mark James Daniel filed Form 4 for ATOSSA THERAPEUTICS, INC. (ATOS) on 21 Oct 2025.

Key facts

This page summarizes Mark James Daniel's Form 4 filing for ATOSSA THERAPEUTICS, INC. (ATOS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Oct 2025, 16:10.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002092593 Primary reporting owner

Daniel Mark James

Relationship: Chief Financial Officer
Address: C/O ATOSSA THERAPEUTICS, INC., 10202 5TH AVENUE NE SUITE 200, SEATTLE
Signature: /s/ Mark James Daniel
Signature date: 21 Oct 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATOS transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +578,000
Change %
Price: $0.000000
Shares after: 578,000
Date: 14 Oct 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 578,000
Exercise price: $1.03
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options shall vest with respect to 25% on October 14, 2026, with the remaining 75% to vest in equal quarterly installments over the follwing three years, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.